Additionally, Sidders et al. have proposed another genomic profile, the “Adenosine Signaling Score”, comprising 14 genes (including PPARG, CYBB, FOXP3, and LAG3), which is closely linked to A2AR signaling in various cancers, thus potentially helping to predict responses to immunotherapy [151]. This evidence concerns the gene ADORA2A and cancer.